| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 338,8 k € | -9.9% | 376,1 k € | +9.8% | 342,4 k € | +32.6% | 258,2 k € | +14.5% | 225,4 k € | -13.2% | 259,7 k € | -26.9% | 355,4 k € | +5.7% | 336,1 k € | -12.2% | 382,6 k € | -18.1% | 467,0 k € | -6.0% | 496,9 k € | +24.7% | 398,4 k € | -5.7% | 422,3 k € | +28.3% | 329,3 k € | -0.3% | 330,1 k € | +21.2% | 272,3 k € | +42.9% | 190,5 k € | +23.4% | 154,4 k € | |
| EBITDA | 331,8 k € | -7.7% | 359,5 k € | +15.2% | 312,2 k € | +36.3% | 229,1 k € | +15.9% | 197,6 k € | -14.4% | 231,0 k € | -23.3% | 301,3 k € | +15.1% | 261,6 k € | -21.4% | 333,0 k € | -20.3% | 418,1 k € | -6.1% | 445,2 k € | +26.1% | 353,1 k € | -8.3% | 385,0 k € | +31.3% | 293,2 k € | -1.5% | 297,5 k € | +24.7% | 238,7 k € | +50.5% | 158,6 k € | +30.8% | 121,2 k € | |
| Operating profit | 303,8 k € | -7.7% | 329,1 k € | +17.2% | 280,9 k € | +47.5% | 190,5 k € | +9.0% | 174,7 k € | -1.3% | 177,0 k € | -28.5% | 247,5 k € | +19.5% | 207,1 k € | -25.0% | 276,2 k € | -22.6% | 356,9 k € | -6.9% | 383,2 k € | +28.3% | 298,7 k € | -8.1% | 325,0 k € | +51.0% | 215,2 k € | -6.3% | 229,5 k € | +49.6% | 153,4 k € | +80.0% | 85,3 k € | +14.3% | 74,6 k € | |
| Profit/loss | 219,4 k € | -6.0% | 233,5 k € | +1.2% | 230,7 k € | +83.8% | 125,5 k € | +8.8% | 115,4 k € | -6.6% | 123,6 k € | -28.3% | 172,4 k € | +24.2% | 138,7 k € | -13.2% | 159,9 k € | -22.9% | 207,4 k € | -15.8% | 246,4 k € | +36.9% | 180,0 k € | -15.5% | 213,1 k € | +49.4% | 142,7 k € | +5.8% | 134,8 k € | +28.1% | 105,2 k € | +207.4% | 34,2 k € | -25.0% | 45,6 k € | |
| Equity | 1,1 M € | +15.3% | 960,0 k € | +16.2% | 826,5 k € | +12.5% | 734,6 k € | -35.8% | 1,1 M € | +11.2% | 1,0 M € | +13.6% | 905,5 k € | +23.5% | 733,2 k € | +23.3% | 594,5 k € | +148.7% | 239,0 k € | -12.0% | 271,6 k € | -1.3% | 275,2 k € | -6.8% | 295,1 k € | +259.8% | 82,0 k € | -65.7% | 239,4 k € | +128.9% | 104,6 k € | -47.4% | 198,9 k € | +20.8% | 164,7 k € | |
| Total assets | 1,2 M € | +7.4% | 1,1 M € | +8.3% | 1,1 M € | +2.6% | 1,0 M € | -14.2% | 1,2 M € | +9.0% | 1,1 M € | +5.7% | 1,0 M € | +15.4% | 908,5 k € | +9.6% | 829,0 k € | +35.3% | 612,9 k € | -8.3% | 668,7 k € | +13.0% | 591,6 k € | -6.3% | 631,3 k € | +6.2% | 594,3 k € | -4.8% | 624,1 k € | +9.2% | 571,3 k € | -16.3% | 682,6 k € | +186.5% | 238,3 k € | |
| Cash | 209,4 k € | +22.2% | 171,3 k € | +87.5% | 91,4 k € | +10.5% | 82,7 k € | -6.3% | 88,4 k € | +74.7% | 50,6 k € | -12.7% | 57,9 k € | +33.8% | 43,3 k € | +6.2% | 40,8 k € | -26.8% | 55,7 k € | -49.3% | 109,7 k € | +54.8% | 70,8 k € | -36.9% | 112,3 k € | +95.5% | 57,4 k € | +74.8% | 32,9 k € | +202.9% | 10,8 k € | -75.9% | 45,1 k € | +582.3% | 6,6 k € | |
| Debts | 127,8 k € | -32.7% | 189,9 k € | -19.4% | 235,6 k € | -21.7% | 301,0 k € | +376.9% | 63,1 k € | -19.7% | 78,6 k € | -44.9% | 142,8 k € | -17.4% | 172,8 k € | -25.5% | 232,0 k € | -37.0% | 368,3 k € | -7.3% | 397,0 k € | +27.4% | 311,6 k € | -7.0% | 335,1 k € | -34.6% | 512,2 k € | +34.3% | 381,5 k € | -18.3% | 466,8 k € | -2.8% | 480,2 k € | +552.7% | 73,6 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||||||||||||
Private limited company · Geel · incorporated on 18/10/1995
Private limited company profitable and well capitalised. Cash position rising (+22.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Rudi HONINX is a Private limited company incorporated in 1995. Its main activity is: Specialist medical practice activities. Its registered office is in Geel.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette